274 related articles for article (PubMed ID: 7621356)
1. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.
Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Frenette R; Gauthier JY; Leger S; Masson P
Can J Physiol Pharmacol; 1989 Jan; 67(1):17-28. PubMed ID: 2540892
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.
Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Gauthier JY; Leger S; Lord A; Masson P
Can J Physiol Pharmacol; 1991 Dec; 69(12):1847-54. PubMed ID: 1666333
[TBL] [Abstract][Full Text] [Related]
4. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.
Jones TR; Young R; Champion E; Charette L; Denis D; Ford-Hutchinson AW; Frenette R; Gauthier JY; Guindon Y; Kakushima M
Can J Physiol Pharmacol; 1986 Aug; 64(8):1068-75. PubMed ID: 3024787
[TBL] [Abstract][Full Text] [Related]
5. L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist.
Jones TR; Guindon Y; Young R; Champion E; Charette L; Denis D; Ethier D; Hamel R; Ford-Hutchinson AW; Fortin R
Can J Physiol Pharmacol; 1986 Dec; 64(12):1535-42. PubMed ID: 3030524
[TBL] [Abstract][Full Text] [Related]
6. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Ishimura M; Kataoka S; Suda M; Maeda T; Hiyama Y
Allergol Int; 2006 Dec; 55(4):403-10. PubMed ID: 17130683
[TBL] [Abstract][Full Text] [Related]
7. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung.
Frey EA; Nicholson DW; Metters KM
Eur J Pharmacol; 1993 Feb; 244(3):239-50. PubMed ID: 8384568
[TBL] [Abstract][Full Text] [Related]
10. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes.
Tudhope SR; Cuthbert NJ; Abram TS; Jennings MA; Maxey RJ; Thompson AM; Norman P; Gardiner PJ
Eur J Pharmacol; 1994 Nov; 264(3):317-23. PubMed ID: 7698171
[TBL] [Abstract][Full Text] [Related]
11. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
Ishimura M; Suda M; Morizumi K; Kataoka S; Maeda T; Kurokawa S; Hiyama Y
Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig.
Hay DW; Muccitelli RM; Vickery-Clark LM; Novak LS; Osborn RR; Gleason JG; Yodis LA; Saverino CM; Eckardt RD; Sarau HM
Pulm Pharmacol; 1991; 4(3):177-89. PubMed ID: 1668219
[TBL] [Abstract][Full Text] [Related]
14. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
16. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
Bäck M; Jonsson EW; Dahlén SE
Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
[TBL] [Abstract][Full Text] [Related]
17. A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid).
Ahnfelt-Rønne I; Kirstein D; Kaergaard-Nielsen C
Eur J Pharmacol; 1988 Oct; 155(1-2):117-28. PubMed ID: 2854067
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
Tomioka K; Yamada T; Mase T; Hara H; Murase K
Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous effect of leucotriene CysLT1 receptor antagonists on antigen-induced motor and inflammatory responses in guinea-pig airways.
Alfieri AB; Tramontana M; Cialdai C; Lecci A; Giuliani S; Crea A; Manzini S; Maggi CA
Auton Autacoid Pharmacol; 2007 Jan; 27(1):39-46. PubMed ID: 17199874
[TBL] [Abstract][Full Text] [Related]
20. Effect of a novel leukotriene D4 antagonist with 5-lipoxygenase and cyclooxygenase inhibitory activity, Wy-45,911, on leukotriene-D4-and antigen-induced bronchoconstriction in the guinea pig.
Chang J; Musser JH; Hand JM
Int Arch Allergy Appl Immunol; 1988; 86(1):48-54. PubMed ID: 2836315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
